1-3 of 3
Maria Concetta Veri
Close
Sort by
Journal Articles

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

Paul A. Moore, Wenjun Zhang, G. Jonah Rainey, Steve Burke, Hua Li, Ling Huang, Sergey Gorlatov, Maria Concetta Veri, Sudeepta Aggarwal, Yinhua Yang, Kalpana Shah, Linda Jin, Sunan Zhang, Leilei He, Tengfei Zhang, Valentina Ciccarone, Scott Koenig, Ezio Bonvini, Syd Johnson
Journal: Blood
Blood (2011) 117 (17): 4542–4551.
https://doi.org/10.1182/blood-2010-09-306449
Published: 2011
Includes: Supplemental data
Journal Articles

An Fc-Optimized Monoclonal Antibody Against CD32B, the Human Inhibitory Fc- γ Receptor IIB, in the Immunotherapy of B-Cell Malignanacy.

Jeffrey B. Stavenhagen, PhD, Sergey Gorlatov, Ph.D., Nadine Tuaillon, Ph.D., Christopher T. Rankin, Ph.D., Maria-Concetta Veri, Ph.D., David Inzunza, M.D., Stephen Burke, Ling Huang, Hua Li, Shannon Thomas, Syd Johnson, Ph.D., Jeffrey Ravetch, M.D., Ph.D., Scott Koenig, M.D., Ph.D., Ezio Bonvini, MD
Journal: Blood
Blood (2006) 108 (11): 2529.
https://doi.org/10.1182/blood.V108.11.2529.2529
Published: 2006
Journal Articles

CD32B, the human inhibitory Fc-γ receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma

Christopher T. Rankin, Maria-Concetta Veri, Sergey Gorlatov, Nadine Tuaillon, Steve Burke, Ling Huang, H. David Inzunza, Hua Li, Shannon Thomas, Syd Johnson, Jeffrey Stavenhagen, Scott Koenig, Ezio Bonvini
Journal: Blood
Blood (2006) 108 (7): 2384–2391.
https://doi.org/10.1182/blood-2006-05-020602
Published: 2006
Includes: Supplemental data